Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.63% to 1,916.85 Indian rupees Tuesday, on what proved to be an all-around great trading session for the stock market, with the BSE SENSEX ...
The Indian pharmaceutical sector faces mixed growth with a 12% YoY and 5% QoQ rise while IPM growth is projected at 8%.
Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.
Stay up-to-date with the Sun Pharmaceutical Industries Stock Liveblog, your trusted source for real-time updates and thorough ...
Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.30% to 1,904.80 Indian rupees Monday, on what proved to be ...
On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...
Fibromun, an innovative anti-cancer immunotherapy, is being investigated in registration trials by Philogen for the treatment ...
The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” after jacking up the ...
Get the latest Business News, Live Share & Stock Market Updates, Top News from India and across world. Read Top Business News ...
Sun Pharma inks a global licensing agreement with Philogen for Fibromun, an anti-cancer immunotherapy, for the treatment of ...
Sun Pharma and Philogen enter into exclusive agreement for commercialising anti-cancer immunotherapy
Under the terms of the agreement, Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun.
Sun Pharma and Philogen partner for global commercialization of innovative anti-cancer immunotherapy Fibromun, aiming to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback